Form 4: TransMedics Group CFO Stephen Gordon Executes Stock Option and Sells Shares
SEC Form 4 Filing
Chief Financial Officer of TransMedics Group, Stephen Gordon, exercised stock options and sold shares on May 6, 2024, according to a recent SEC filing.
Summary
- Stephen Gordon, the CFO of TransMedics Group, exercised stock options to acquire 15,000 shares of common stock at a price of $38.46 on May 6, 2024.
- Simultaneously, Gordon sold 15,000 shares of common stock at $128 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on September 14, 2023.
- Following these transactions, Gordon directly owns 23,299 shares of TransMedics Group common stock.
- Gordon also holds options to purchase 22,477 shares.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of insider trading activity under a pre-existing plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans to avoid accusations of trading on inside information. The market will likely interpret this as a standard transaction unless there are unusual patterns or amounts involved.
Key Dates
| Date | Description |
|---|---|
| 09/14/2023 | Date of establishment of Rule 10b5-1 trading plan |
| 02/24/2025 | Date the option is fully vested |
| 02/24/2031 | Expiration date of the stock option |
| 05/06/2024 | Date of stock option exercise and share sale |
| 05/08/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.